Literature DB >> 12594338

Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter.

Simos Simeonidis1, Ignazio Castagliuolo, Amy Pan, Jennifer Liu, Chi-Chi Wang, Andreas Mykoniatis, Asia Pasha, Leyla Valenick, Stavros Sougioultzis, Dezheng Zhao, Charalabos Pothoulakis.   

Abstract

We report here that human monocytic/macrophage THP-1 cells express the neurokinin 1 receptor (NK-1R), and that exposure of these cells to the proinflammatory cytokine IL-1 beta increased the expression of the NK-1R gene at the mRNA and protein levels. Because IL-1 beta function involves nuclear factor kappa B (NF-kappa B) activation, these data suggest that this increase in the expression of the NK-1R gene is mediated by the NF-kappa B transcription factor. An earlier report noted that the promoter region of the human NK-1R gene contains a putative binding site for NF-kappa B [Takahashi, K., Tanaka, A., Hara, M. & Nakanishi, S. (1992) Eur. J. Biochem. 204, 1025-1033]. Here we demonstrate that this is indeed a functional NF-kappa B-binding site, and that NF-kappa B is responsible for regulating the expression of the NK-1R gene by binding to the promoter region of the NK-1R gene. To further substantiate that the observed NF-kappa B-dependent IL-1 beta induction of the human NK-1R gene is regulated via a transcriptional event through this NF-kappa B site on the NK-1R gene promoter, we transfected THP-1 cells with a luciferase promoter-reporter construct containing the 5' promoter region of the human NK-1R gene. Exposure of these cells to IL-1 beta or overexpression of NF-kappa B cDNAs resulted in a significant increase in the amount of luciferase activity that was diminished greatly in cells transfected with I kappa B alpha, the NF-kappa B inhibitor. These results directly implicate NF-kappa B in the regulation of the NK-1R gene and provide a molecular mechanism for the increase in expression of the NK-1R gene in responsive cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594338      PMCID: PMC151448          DOI: 10.1073/pnas.0530112100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation.

Authors:  E Goldin; F Karmeli; Z Selinger; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

Review 2.  NF-kappa B: a lesson in family values.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

3.  The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.

Authors:  B L Fiebich; S Schleicher; R D Butcher; A Craig; K Lieb
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

4.  CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Authors:  C Pothoulakis; I Castagliuolo; J T LaMont; A Jaffer; J C O'Keane; R M Snider; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

5.  Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor.

Authors:  G A Cook; D Elliott; A Metwali; A M Blum; M Sandor; R Lynch; J V Weinstock
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

6.  Substance P dependence of endosomal fusion during bladder inflammation.

Authors:  T G Hammond; R Saban; K L Bost; H W Harris; J H Kaysen; F O Goda; X C Wang; F C Lewis; G L Navar; W C Campbell; D E Bjorling; M Saban; M L Zeidel
Journal:  Am J Physiol Renal Physiol       Date:  2000-03

7.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  The primary structure and gene organization of human substance P and neuromedin K receptors.

Authors:  K Takahashi; A Tanaka; M Hara; S Nakanishi
Journal:  Eur J Biochem       Date:  1992-03-15

9.  Identification of the rel family members required for virus induction of the human beta interferon gene.

Authors:  D Thanos; T Maniatis
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

10.  Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones.

Authors:  M K Schäfer; D Nohr; J E Krause; E Weihe
Journal:  Neuroreport       Date:  1993-08       Impact factor: 1.837

View more
  37 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

Review 2.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

3.  Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals.

Authors:  Steven D Douglas; Kevin G Lynch; Jian-Ping Lai
Journal:  J Neurol Sci       Date:  2008-06-24       Impact factor: 3.181

4.  Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.

Authors:  Tilman E Klassert; Shyam A Patel; Pranela Rameshwar
Journal:  J Receptor Ligand Channel Res       Date:  2010-04-01

5.  Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway.

Authors:  Claudio Bardelli; Gabriele Gunella; Federica Varsaldi; Pietro Balbo; Elisa Del Boca; Ilaria Seren Bernardone; Angela Amoruso; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

6.  Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.

Authors:  Hon-Wai Koon; Dezheng Zhao; Yanai Zhan; Sang Hoon Rhee; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

7.  Role of Spinal Microglia in Visceral Hyperalgesia and NK1R Up-Regulation in a Rat Model of Chronic Stress (Gastroenterology 2009;136:1339-1348).

Authors:  Su Jin Hong
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

8.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

9.  A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages.

Authors:  A Amoruso; C Bardelli; G Gunella; F Ribichini; S Brunelleschi
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

10.  Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.

Authors:  Iordanes Karagiannides; Efi Kokkotou; Morris Tansky; Tamara Tchkonia; Nino Giorgadze; Michael O'Brien; Susan E Leeman; James L Kirkland; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.